Epidemiology of Paramyxoviridae

  • Francis L. Black
Part of the The Viruses book series (VIRS)


All Paramyxoviridae are extremely infectious, and there is little chance for anybody living in a cosmopolitan community to get through a full life without being infected by wild or attenuated forms of all the paramyxoviruses adapted to humans. Their common structure is labile and all viruses of this family are dependent on transmission by close association of hosts. They do not survive drying on a solid surface, nor are they sufficiently stable in water to be transmitted by this vehicle with regularity. They are inactivated by stomach acid and intestinal enzymes, and do not infect via the gut. Very efficient infection occurs through aerosolized virus, and direct physical contact between hosts is not required. Drying in an aerosol does not inactivate them and it is probably the surface tension forces involved in drying on a surface, not drying per se, that inactivates. Urine may be an important source of the aerosols (Gresser and Katz, 1960). These viruses infect through mucous membranes (Papp, 1956; Black and Sheridan, 1960), but measles virus, at least, infects most efficiently when introduced in droplets small enough to reach into the lungs (McCrumb et al., 1962).


Respiratory Syncytial Virus Newcastle Disease Virus Measle Virus Respiratory Syncytial Virus Infection Measle Vaccine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Aaby, P., 1988, Malnutrition and overcrowding/intensive exposure in severe measles infection: Review of community studies, Rev. Infect. Dis. 10:478–491.PubMedCrossRefGoogle Scholar
  2. Aaby, P., Bukh, J., Lisse, I. M., and Smits, A. J., 1983, Measles mortality, state of nutrition and family structure: A community study from Guinea Bissau, J. Infect. Dis. 147:693–701.PubMedCrossRefGoogle Scholar
  3. Aaby, P., Bukh, J., Lisse, I. M., and Smits, A. J., 1986, Severe measles in Sunderland, 1885; A European—African comparison of causes of severe infection, Int. J. Epidemiol. 15:101–107.PubMedCrossRefGoogle Scholar
  4. Adams, J. M., Imagawa, D. T., Wright, S. W., and Tarjan, G., 1959, Measles immunization with live avian distemper virus, Virology 7:353–354.CrossRefGoogle Scholar
  5. Advisory Committee on Immunization Practices, 1989, Measles prevention. Supplemental statement, Morbid. Mortal Weekly Rep. 38:11–14.Google Scholar
  6. American Veterinary Medical Association, 1986, J. Am. Vet. Med. Assoc. 1986:281–284.Google Scholar
  7. Anderson, L. J., Hierholzer, J. C., Tsou, C., Hendry, R. M., Fernie, B. F., Stone, Y., and McIntosh, K., 1985, Antigenic characterization of repiratory syncytial strains with monoclonal antibodies, J. Infect. Dis. 151:633.Google Scholar
  8. Anderson, R. M., 1982, Transmission dynamics and control of infectious agents, in “Population Biology of Infectious Disease” (R. M. Anderson and R. M. May, eds.), pp. 149–176, Springer-Verlag, New York.CrossRefGoogle Scholar
  9. Anderson, R. M., and May, R. M., 1985, Vaccination and herd immunity to infectious diseases, Nature 318:323–329.PubMedCrossRefGoogle Scholar
  10. Anderson, R. M., Crombie, J. A., and Grenfell, B. T., 1987, The epidemiology of mumps in the U.K.: A preliminary study of virus transmission, herd immunity and the potential impact of immunization, Epidemiol. Infect. 99:65–84.PubMedCrossRefGoogle Scholar
  11. Andrewes, C. H., 1972, “Viruses of Vertebrates,” Williams and Wilkins, Baltimore, Maryland.Google Scholar
  12. Appel, M. J. G., and Gillespie, J. H., 1972, “Canine Distemper Virus,” Springer-Verlag, Berlin.CrossRefGoogle Scholar
  13. Appel, M. J. G., Shek, W. R., Sheshberadaran, H., and Norrby, E., 1984, Measles virus and inactivated canine distemper virus induced incomplete immunity to canine distemper, Arch. Virol. 82:73–82.PubMedCrossRefGoogle Scholar
  14. Babbitt, F. L., Jr., and Gordon, J. E., 1954, Modern measles, Am. J. Med. Sci. 228:334–361.Google Scholar
  15. Babbitt, F. L., Galbraith, N. S., McDonald, J. C., Shaw, A., and Zuckerman, A. J., 1963, Deaths from measles in England and Wales in 1961, Mon. Bull. Minist. Health Pub. Health Lab. Serv. 22:167–175.Google Scholar
  16. Bartlett, M. S., 1956, Deterministic and stochastic models for recurrent epidemics, in “Third Berkeley Symposium on Mathematical Statistics and Probability,” Vol. 4, pp. 81–109.Google Scholar
  17. Bartlett, M. S., 1957, Measles periodicity and community size, J. R. Stat. Soc. A 120:40–70.Google Scholar
  18. Beem, M., 1967, Repeated infections with respiratory syncytial virus, J. Immunol. 98:1115–1122.PubMedGoogle Scholar
  19. Belshe, R. B., and Hissom, F. K., 1982, Cold-adaptation of parainfluenza virus type 3: Induction of three phenotype markers, J. Med. Virol. 10:235–242.PubMedCrossRefGoogle Scholar
  20. Bhatt, P. N., Brandt, C. D., Weiss, R. A., Fox, J. P., and Shaffer, M. F., 1966, Viral infections of monkeys in the natural habitat in southern India, Am. f. Trop. Med. Hyg. 15:561–566.Google Scholar
  21. Bisno, A. L., Barratt, N. P., Swanston, W. H., and Spence, L. P., 1970, An outbreak of acute respiratory disease in Trinidad associated with parainfluenza viruses, Am. J. Epidemiol. 91:68–77.PubMedGoogle Scholar
  22. Black, F. L., 1959, Measles antibodies in the population of New Haven, Conn, 1959, J. Immunol. 83:74–82.PubMedGoogle Scholar
  23. Black, F. L., 1962, Measles antibody prevalence in diverse populations, Am. f. Dis. Child. 103:242–249.Google Scholar
  24. Black, F. L., 1964, A nationwide serum survey of United States military recruits, 1962. III. Measles and mumps antibodies, Am. J. Hyg. 80:304–307.PubMedGoogle Scholar
  25. Black, F. L., 1965, Measles endemicity ininsular populations: Critical community size and its evolutionary implication, Theor. Biol. 11:207–211.CrossRefGoogle Scholar
  26. Black, F. L., 1982, The role of herd immunity in the control of measles, Yale J. Biol. Med. 55:351–360.PubMedGoogle Scholar
  27. Black, F. L., 1989a, Measles active and passive immunity in a worldwide perspective, Prog. Med. Virol. 36:1–33.PubMedGoogle Scholar
  28. Black, F. L., 1989b, Measles, in “Viral Infections of Humans,” 3rd ed. (A. S. Evans, ed.), pp. 450–470, Plenum Press, New York.Google Scholar
  29. Black, F. L., 1989c, The age when the window of opportunity for vaccination against measles opens and closes in diverse countries, in “Proceedings of the Symposium on Infectious Diseases in Developing Countries,” pp. 93–100, South African Medical Research Council, Johannesberg, South Africa.Google Scholar
  30. Black, F. L., and Davis, D. E. M., 1968, Measles and readiness for reading and learning. II. New Haven study, Am. J. Epidemiol. 88:337–344.PubMedGoogle Scholar
  31. Black, F. L., and Houghton, W. J., 1967, The significance of mumps hemagglutination inhibition titers in normal populations, Am. J. Epidemiol. 85:101–107.PubMedGoogle Scholar
  32. Black, F. L., and Sheridan, S. R., 1960, Studies on attenuated measles vaccine. IV. Administration of vaccine by several routes, N. Engl. J. Med. 263:166–170.CrossRefGoogle Scholar
  33. Black, F. L., and Singer, B., 1987, Elaboration versus simplification in refining mathematical models of infectious disease, Annu. Rev. Microbiol. 41:677–701.PubMedCrossRefGoogle Scholar
  34. Black, F. L., and Yannet, H., 1960, Inapparent measles after gamma globulin administration, J. Am. Med. Assoc. 173:1183–1188.CrossRefGoogle Scholar
  35. Black, F. L., Hierholzer, W. H., Woodall, J. P., and Pinheiro, F. P., 1971, Intensified reactions to measles vaccine in unexposed populations of American Indians, J. Infect. Dis. 124:306–317.PubMedCrossRefGoogle Scholar
  36. Black, F. L., Hierholzer, W. H., Pinheiro, F. P., Evans, A. S., Woodall, J. P., Opton, E.M., Emmons, J. E., West, B. S., Edsall, G., Downs, W. G., and Wallace, G. D., 1974, Evidence for persistence of infectious agents in isolated populations, Am. J. Epidemiol. 100:230–250.PubMedGoogle Scholar
  37. Black, F. L., Pinheiro, F. P., Hierholzer, W. H., and Lee, R. V., 1977, Epidemiology of infectious disease: The example of measles, in “Health and Disease in Tribal Societies,” pp. 115–143, Ciba Foundation.Google Scholar
  38. Black, F. L., Berman, L. L., Borgono, J. M., Capper, R. A., Carvalho, A. A., Collins, C., Glover, O., Hijazi, Z., Jacobson, F. L., Lee, Y.-L., Libel, M., Linhares, A. C., Mendizabal-Morris, C. A., Simoes, E., Siqueira-Campos, E., Stevenson, J., and Vecchi, N., 1987, Geographic variation in infant loss of maternal antibody and in prevalence of rubella antibody, Am. J. Epidemiol. 124:442–452.Google Scholar
  39. Brandt, C. D., Kim, H. W., Arrobio, J. O., Wood, S. C., Channock, R. M., and Parrott, R. H., 1973, Epidemiology of respiratory syncytial virus infection in Washington, D.C. III. Composite analysis of eleven consecutive yearly epidemics, Am. J. Epidemiol. 98:355–364.PubMedGoogle Scholar
  40. Brandt, C. D., Kim, H. W., Channock, R. M., and Parrott, R. S., 1974, Parainfluenza epidemiology, Pediatr. Res. 8:422.CrossRefGoogle Scholar
  41. Buynak, E. B., Whitman, J. E., Roehm, R. R., Morton, D. H., Lampson, G. P., and Hilleman, M. R., 1967, Comparison of neutralization and hemagglutination-inhibition techniques for measuring mumps antibody, Proc. Soc. Exp. Biol. Med. 125:1068–1071.PubMedGoogle Scholar
  42. Buynak, E. B., Weibel, R. E., McLean, A. A., and Hilleman, M. R., 1978, Live respiratory syncytial virus vaccine administered parenterally, Proc. Soc. Exp. Biol. Med. 157:636–642.PubMedGoogle Scholar
  43. Carrada Bravo, T., and Velazquez Diaz, G., 1980, El impacto del sarampion en Mexico, Salud Pub. Mex. 22:359–405.Google Scholar
  44. Communicable Disease Center, 1966, “Measles Surveillance, Report No. 3,” Department of Health Education and Welfare Publication.Google Scholar
  45. Center for Disease Control, 1973, Mumps Surveillance, DHEW Publication 73-8178, Washington, D.C.Google Scholar
  46. Center for Disease Control, 1975, Mumps Surveillance January 1972–June 1974, DHEW Publication 75-8178, Washington, D.C.Google Scholar
  47. Center for Disease Control, 1978, Annual summary, 1977, Morbid. Mortal. Weekly Rep. 26(53):56.Google Scholar
  48. Centers for Disease Control, 1982, Subacute sclerosing panencephalitis surveillance—United States, Morbid. Mortal. Weekly Rep. 31:385–388.Google Scholar
  49. Centers for Disease Control, 1983, Chains of measles transmission—United States, Morbid. Mortal. Weekly Rep. 32:282–284.Google Scholar
  50. Centers for Disease Control, 1987, Mumps outbreaks on university campuses—Illinois, Wisconsin, South Dakota, Morbid. Mortal. Weekly Rep. 36:496–498, 503-505.Google Scholar
  51. Centers for Disease Control, 1988, Summary of notifiable diseases. United States, 1987, Morbid. Mortal. Weekly Rep. 36:(54):30.Google Scholar
  52. Centers for Disease Control, 1989a, Measles—Chicago, Morbid. Mortal. Weekly Rep. 38:591–592.Google Scholar
  53. Centers for Disease Control, 1989b, Measles—United States, 1988, Morbid. Mortal. Weekly Rep. 38:601–605.Google Scholar
  54. Chalmers, A. K., 1930, “The Health of Glasgow 1818–1925,” Bell and Blain, Glasgow.Google Scholar
  55. Chang, W. K., 1982, A review of viral diseases in Honk Kong, in “Viral Diseases in South-East Asia and the Western Pacific” (J. S. Mackenzie, ed.), pp. 229–235, Academic Press, Sydney, Australia.Google Scholar
  56. Channock, R. M., Kim, H. W., Brandt, C. D., and Parrott, R. H., 1989, Respiratory syncytial virus, in “Viral Infections of Humans,” 3rd ed., (A. S. Evans ed.), pp. 525–544, Plenum Press, New York.CrossRefGoogle Scholar
  57. Chen, L. C., Chowdhury, A. K. M. A., and Huffman, S. L., 1980, Anthropomorphic assessment of energy-protein malnutrition and subsequent risk of mortality among preschool aged children, Am. J. Clin. Nutr. 33:1836–1845.PubMedGoogle Scholar
  58. Chin, J., Magoffin, R. L., Shearer, L. A., Schieble, J. H., and Lennette, E. H., 1969, Field evaluation of a respiratory syncytial virus vaccine and a trivalent parainfluenza virus vaccine in a pediatric population, Am. J. Epidemiol 89:449–463.PubMedGoogle Scholar
  59. Christensen, P. E., Schmidt, H., Bang, H. O., Andersen, V., Jordal, B., and Jensen, O., 1953, An epidemic of measles in southern Greenland, 1951. Measles in virgin soil. II. The epidemic proper, Acta Med. Scand. 144:430–449.PubMedCrossRefGoogle Scholar
  60. Christie, C. D., Lee-Hirsh, J., Rogall, B., Merrill, S., Ramlal, A., Karian, V., and Black, F. L., 1990, Durability of passive measles antibody in Jamaican Children, Int. J. Epidemiol. 19:in press.Google Scholar
  61. Cliff, A. D., and Haggett, P., 1985, The Spread of Measles in Fiji and the Pacific, Department of Human Geography, Publication 18, Australian National University, Canberra, Australia.Google Scholar
  62. Cochi, S. L., Preblud, S. R., and Orenstein, W. A., 1988, Perspectives on the relative resurgence of mumps in the United States, Am. f. Dis. Child. 142:499–507.Google Scholar
  63. Collins, C. M., 1987, Two studies which evaluate measles control in South Africa: L Status of maternal-fetal immunoglobulin transfer in a South African “Homeland.” II. Premature vaccination in Black children and the effect on revaccination, Thesis, Yale University School of Medicine, New Haven, Connecticut.Google Scholar
  64. Communicable Disease Center, 1966, Measles Surveillance, Report No. 3, DHEW, Washington, D.C.Google Scholar
  65. Cooney, M. K., Fox, J. P., and Hall, C. E., 1975, The Seattle virus watch. VI. Observation of infections with and illness due to parainfluenza, mumps, and respiratory syncytial viruses and Mycoplasma pneumoniae, Am. J. Epidemiol. 101:532–542.PubMedGoogle Scholar
  66. Dabis, F., Sow, A., Waldman, R. J., Bikakouri, P., Senga, J., Madzou, G., and Jones, T. S., 1988, Loss of maternal antibody during infancy in an African city, Am. J. Epidemiol. 127:171–178.PubMedGoogle Scholar
  67. Denny, F. W., and Clyde, W. A., 1986, Acute lower respiratory tract infections in non-hospitalized children, J. Pediatr. 108:635–646.PubMedCrossRefGoogle Scholar
  68. Detels, R., Brody, J. A., McNew, J., and Edgar, A. H., 1973, Further epidemiologic studies of subacute sclerosing panencephalitis, Lancet 2:11–14.PubMedCrossRefGoogle Scholar
  69. Dickson, D., 1988, Canine distemper may be killing North Sea seals, Science 241:1284.PubMedCrossRefGoogle Scholar
  70. Doraisingham, S., 1982, Viral diseases in Singapore—A national overview, in “Viral diseases in South-East Asia and the Western Pacific” (J. S. Mackenzie, ed.), pp. 229–235, Academic Press, Sydney, Australia.Google Scholar
  71. Feldman, H. A., 1989, Mumps, in “Viral Infections in Humans,” 3rd ed. (A. S. Evans, ed.), pp. 471–491, Plenum Press, New York.CrossRefGoogle Scholar
  72. Fine, P. E. M., and Clarkson, J. A., 1982, Measles in England and Wales—I: An analysis of factors underlying seasonal patterns, Int. J. Epidemiol. 11:5–14.PubMedCrossRefGoogle Scholar
  73. Fox, J. P., Black, F. L., and Kogon, S. A., 1968, Measles and readiness for reading and learning. V. Evaluative comparison of the studies and overall conclusions, Am. J. Epidemiol. 88:359–367.PubMedGoogle Scholar
  74. Frost, W. H., 1976, Some conceptions of epidemics in general, Am. f. Epidemiol. 94:179–189.Google Scholar
  75. Gardner, S. D., 1969, The isolation of parainfluenza 4 subtypes A and B in England and serological studies of their prevalence, J. Hyg. (Camb.) 67:545–550.CrossRefGoogle Scholar
  76. Gibbs, F. A., Gibbs, E. L., Carpenter, P. R., and Spies, H. W., 1959, Electroencephalographic abnormality in “uncomplicated” measles, J. Am. Med. Assoc. 171:1050–1055.PubMedCrossRefGoogle Scholar
  77. Glezen, W. P., Paredes, A., Allison, J. E., Tabor, L. H., and Frank, A. L., 1981, Risk of respiratory syncytial virus infection for infants from low-income families in relationship to age, sex, ethnic group and maternal antibody titer, J. Pediati. 98:708–715.CrossRefGoogle Scholar
  78. Glezen, W. P., Frank, A. L., Taber, L. H., and Kasel, J. A., 1984, Parainfluenza virus type 3: Seasonality and risk of infection and reinfection in young children, J. Infect. Dis. 150:851–857.PubMedCrossRefGoogle Scholar
  79. Glezen, W. P., Loda, F. A., and Denny, F. W., 1989, Parainfluenza viruses, in “Viral Infections of Humans,” 3rd ed. (A. S. Evans, ed.), pp. 493–507, Plenum Press, New York.CrossRefGoogle Scholar
  80. Golubjatnikov, R., Allen, V. D., Olmos-Blancarte, M. P., and Inhorn, S. L., 1975, Serologic profile of children in a Mexican highland community: Prevalence of complement-fixing antibody to Mycoplasma pneumoniae, respiratory syncytial virus and parainfluenza viruses, Am. J. Epidemiol. 101:458–464.PubMedGoogle Scholar
  81. Gordon, J. E., and Kilham, L., 1949, Ten years in the epidemiology of mumps, Am. J. Med. Sci. 218:338–359.PubMedCrossRefGoogle Scholar
  82. Greenberg, M., Pelliteri, O., and Eisenstein, D. T., 1955, Measles encephalitis. I. Prophylactic effect of gamma globulin, J. Pediati. 46:642–647.CrossRefGoogle Scholar
  83. Gresser, I., and Katz, S. L., 1960, Isolation of measles virus from urine, N. Engl. J. Med. 263:452–454.PubMedCrossRefGoogle Scholar
  84. Grey, R. H., Char, G., Prabhakar, R., Bainbridge, R., and Johnson, B., 1986, Subacute sclerosing panencephalitis in Jamaica, W. Indies Med. J. 35:27–34.Google Scholar
  85. Gross, P. A., Green, R. H., and McCrea-Curnen, M. G., 1973, Persistent infection with parainfluenza type 3 virus in man, Am. Rev. Respir. Dis. 108:894–898.PubMedGoogle Scholar
  86. Guyer, B., and McBean, A. M., 1981, The epidemiology and control of measles in Yaounda, Cameroun, 1968–1975, Int. J. Epidemiol. 10:263–269.PubMedCrossRefGoogle Scholar
  87. Hall, C. B., Geiman, J. M., Biggar, R., Kotok, D. I., Hogan, P. M., and Douglas, R. G., 1976, Respiratory syncyial virus infections within families, N. Engl. J. Med. 294:414–419.PubMedCrossRefGoogle Scholar
  88. Halsey, N. A., Modlin, J. F., Jabbour, J. T., Dubey, L., Eddins, D. L., and Ludwig, D. L., 1980, Risk factors in SSPE: A case control study, Am. J. Epidemiol. 111:415–431.PubMedGoogle Scholar
  89. Hamer, W. H., 1906, The Milroy lectures on epidemic disease in England—The evidence of variability and persistency of type, Lancet 1:733–739.Google Scholar
  90. Hedrich, A. W., 1933, Monthly estimates of the child population susceptible to measles 1900–1931, Am. J. Hyg. 17:613–636.Google Scholar
  91. Henderson, F. W., Collier, A. M., Clyde, W. A., and Denny, F. W., 1979, Respiratory syncytial virus infection, reinfection and immunity: A prospective longitudinal study in young children, N. Engl. Med. J. 300:530–535.CrossRefGoogle Scholar
  92. Hendry, R. M., Burns, J. C., Walsh, E. E., Graham, B. S., Wright, P. F., Hemming, V. G., Rodriguez, W. J., Kim, H. W., Prince, G. A., McIntosh, K., Channock, R. M., and Murphy, B. R., 1988, Strainspecific antibody responses in infants undergoing primary infection with respiratory syncytial virus, J. Infect. Dis. 157:640–647.PubMedCrossRefGoogle Scholar
  93. Hinman, A. R., Brandlin-Bennett, A. D., and Nieberg, P. I., 1979, The opportunity and obligation to eliminate measles from the United States, J. Am. Med. Assoc. 242:1157–1161.CrossRefGoogle Scholar
  94. Hirsh, A., 1883, “Handbook of Geographical and Historical Pathology,” Vol. I, p. 163, New Sydenham Society, London.Google Scholar
  95. Hsiung, G. D., Isacson, P., and Tucker, G., 1963, Studies of parainfluenza viruses. II. Serologic interrelationships in humans, Yale J. Biol. Med. 35:534–544.PubMedGoogle Scholar
  96. Hull, R. N., Minner, J. R., and Smith, J. W., 1956, New agents recovered from tissue cultures of monkey kidney cells, Am. J. Hyg. 63:204–215.PubMedGoogle Scholar
  97. John, T. J., Joseph, A., George, T. I., Radakrishnan, J., Singh, R. D. P., and George, K. G., 1980, Epidemiology and prevention of measles in rural South India, Ind. J. Med. Res. 72:153–158.Google Scholar
  98. Joosting, A. C. C., Harwin, R. M., Orchard, M., Martin, E., and Gear, J. H. S., 1979, Respiratory viruses in hospital patients on the Witwatersrand, S. Afr. Med. J. 55:403–409.PubMedGoogle Scholar
  99. Kapikian, A. Z., Mitchell, R. H., Channock, R. M., Shvedoff, R. A., and Stewart, C. E., 1969, An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine, Am. J. Epidemiol. 89:405–421.PubMedGoogle Scholar
  100. Kaplan, K. M., Marder, D. C., Cochi, S. L., and Preblud, S. R., 1988, Mumps in the workplace. Further evidence of the changing epidemiology of a childhood vaccine-preventable disease, J. Am. Med. Assoc. 260:1434–1438.CrossRefGoogle Scholar
  101. Karim, A., Ghoneim, N. H., Wood, G. T., Marsfield, M. E., and Brown, J. R., 1985, A serologic epidemiological study of parainfluenza 1, 2 and 3 viruses in beef cattle and calves in Illinois, Res. Commun. Chem. Pathol. Pharmacol. 47:437–440.PubMedGoogle Scholar
  102. Katz, S. L., 1985, Measles—Forgotten but not gone, N. Engl. J. Med. 313:577–578.PubMedCrossRefGoogle Scholar
  103. Kim, H. W., Canchola, J. G., Brandt, C. D., Pyles, G., Channock, R. M., Jensen, K., and Parrott, R. H., 1969, Respiratory syncytial disease in infants despite prior administration of antigenic inactivated vaccine, Am. J. Epidemiol. 89:422–434.PubMedGoogle Scholar
  104. Kimman, T. G., Zimmer, G. M., Wesrtenbrink, F., Mars, J., and van Leuwen, E., 1988, Epidemiologic study of bovine respiratory syncytial virus infection in calves: Influence of maternal antibodies on the outcome of disease, Vet. Rec. 123:104–109.PubMedCrossRefGoogle Scholar
  105. Kogon, A., Hall, C. E., Cooney, M. K., and Fox, J. P., 1968, Measles and readiness for reading and learning. IV Shoreline school district study, Am. J. Epidemiol. 88:351–358.PubMedGoogle Scholar
  106. Koster, F. T., Curlin, G. C., Aziz, K. M. A., and Haque, A., 1981, Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh, Bull. World Health Org. 59:901–908.PubMedGoogle Scholar
  107. Kress, S., Schluederberg, A. E., Hornick, R. B., Morse, L. J., Cole, J. L., Slater, E. A., and McCrumb, F. R., 1961, Studies with live attenuated measles vaccine, Am. J. Dis. Child. 101:701–707.PubMedGoogle Scholar
  108. Lennon, J. L., and Black, F. L., 1986, Maternally derived measles immunity in the era of vaccine-protected mothers, J. Pediat. 108:671–676.PubMedCrossRefGoogle Scholar
  109. Mata, L. J., 1978, “The children of Santa Maria Cauque,” MIT Press, Cambridge, Massachusetts.Google Scholar
  110. Maynard, J. E., Felz, E. T., Wulff, H., Fortuine, R., Poland, J. D., and Chin, T. D. Y., 1967, Surveillance of respiratory infection among Alaskan Eskimo children, J. Am. Med. Assoc. 200:927–931.CrossRefGoogle Scholar
  111. Maynard, J. E., Shramek, G., Noble, G. R., Deinhardt, F., and Clark, P., 1970, Use of attenuated live mumps vaccine during a “virgin soil” epidemic of mumps on St. Paul Island, Alaska, Am. J. Epidemiol. 92:301–306.PubMedGoogle Scholar
  112. McCandish, I. E., Thompson, H., Cornwell, H. G., and Wright, N. G., 1978, A study of dogs with kennel cough, Vet. Rec. 102:293–301.CrossRefGoogle Scholar
  113. McCrumb, F. R., Jr., Kress, S., and Saunders, E., 1962, Studies with live attenuated measles-virus vaccine. I. Clinical and immunologic responses in institutionalized children, Am. J. Dis. Child. 101:687–707.Google Scholar
  114. McIntosh, K., and Fishaut, M., 1980, Immunopathologic mechanisms in lower respiratory tract disease of infants due to respiratory syncytial virus, Prog. Med. Virol. 26:94–118.PubMedGoogle Scholar
  115. Meyer, M. B., 1962, An epidemiologic study of mumps; Its spread in schools and families, Am. J. Hyg. 75:259–281.PubMedGoogle Scholar
  116. Miller, M. E., and Stiehm, E. R., 1983, Immunology and resistance to infection, in “Infectious Diseases of the Fetus and Newborn Infant” (J. S. Remington and J. O. Klein, eds.), Saunders, Philadelphia.Google Scholar
  117. Miller, W. S., and Artenstein, M. S., 1967, Aerosol stability of three acute respiratory disease viruses, Proc. Soc. Exp. Biol. Med. 127:222–227.Google Scholar
  118. Modlin, J. F., Jabbour, J. T., Witte, J. J., and Halsey, N. A., 1977, Epidemiologic studies of measles, measles vaccine and subacute sclerosing panencephalitis, Pediatrics 59:505–512.PubMedGoogle Scholar
  119. Montali, R. J., Bartz, C. R., Teare, J. A., Allen, J. T., Appel, M. J. G., and Bush, M., 1983, Clinical trials with canine distemper vaccines in exotic carnivores, J. Am. Vet. Med. Assoc. 183:1163–1167.PubMedGoogle Scholar
  120. Monto, A. S., Koopman, J. S., and Bryan, E. R., 1986, The Tecumseh study of illness. XIV. Occurrence of respiratory viruses, 1976–1981, Am. J. Epidemiol. 124:359–367.PubMedGoogle Scholar
  121. Morely, D. C., Martin, W. J., and Allen, I., 1967, Measles in West Africa, W. Afr. Med. J. 16:24–31.Google Scholar
  122. Mufson, M. A., Mocega, H. E., and Krause, H. E., 1973, Acquisition of parainfluenza 3 virus infection by hospitalized children. I. Frequencies, rates, and temporal data, J. Infect. Dis. 128:141–147.PubMedCrossRefGoogle Scholar
  123. Mufson, M. A., Belshe, R. B., Örvell, C., and Norrby, E., 1988, Respiratory syncytial virus epidemic: Variable dominance of subgroups A and B strains among children 1981–1986, J. Infect. Dis. 157:143–148.PubMedCrossRefGoogle Scholar
  124. Neel, J. V., Centerwall, W. R., Chagnon, N. A., and Casey, H. L., 1970, Notes on the effect of measles and measles vaccine in a virgin-soil population of South American Indians, Am. J. Epidemiol. 91:418–429.PubMedGoogle Scholar
  125. Newell, K. W., Lehmann, A. D., Leblanc, D. R., and Osorio, N. G., 1966, The use of toxoid for the prevention of tetanus neonatorum. Final report of a double-blind controlled field trial, Bull. World Health Org. 35:863–871.PubMedGoogle Scholar
  126. Niederman, J. C., Henderson, J. R., Opton, E. M., Black, F. L., and Skrnova, K., 1967, A nationwide survey of Brazilian military recruits, 1964. II, Antibody patterns with arboviruses, polioviruses, measles and mumps, Am. J. Epidemiol. 86:319–329.PubMedGoogle Scholar
  127. Norrby, E., Sheshberadaran, H., and McCollogh, K. C., 1985, Is rinderpest the archetype of the Morbillivirus genus?, Intervirology 23:228–232.PubMedCrossRefGoogle Scholar
  128. Ogilvie, M. M., Santhire Vathenen, A., Radford, M., Codd, J., and Key, S., 1981, Maternal antibody and respiratory syncytial virus infection in infancy, J. Med. Virol. 7:263–272.PubMedCrossRefGoogle Scholar
  129. Osterhause, A. D. M. E., and Vedder, E. J., 1988, Identification of virus causing recent seal deaths, Nature 335:20.CrossRefGoogle Scholar
  130. Pachman, D. J., 1988, Mumps occurring in previously vaccinated adolescents Am. J. Dis. Child. 142:478–479.PubMedGoogle Scholar
  131. Pan American Health Organization, 1988, Reported cases of EPI diseases, EPI Newsl. 10:7.Google Scholar
  132. Pampiglione, G., 1964, Prodromal phase of measles: Some neurophysiological studies, Br. Med. J. ii:1296–1300.Google Scholar
  133. Panum, P. L., 1940, “Observations Made during the Epidemic of Measles on the Faroe Islands in the Year 1846,” American Publishing Association, New York.Google Scholar
  134. Papp, K., 1956, Experiences prouvant que la voie d’infection de la rougeole est la contamination de la muguese conjontivale, Rev. Immunol. 20:27–36.Google Scholar
  135. Parker, J. C., and Richter, C. D., 1986, Viral diseases of the respiratory system, in “The Mouse in Biomedical Research” (H. L. Foster, J. D. Small, and J. C. Foxe, eds.), pp. 109–158, Academic Press, New York.Google Scholar
  136. Parrott, R. H., Kim, H. W., Arrobio, J. O., Hodes, D. S., Murphy, B. R., Brandt, C. D., Camargo, E., and Channock, R. M., 1973, Epidemiology of respiratory syncytial virus infection in Washington, D.C. II. Infection and disease with respect to age, immunologic status, race and sex, Am. J. Epidemiol 98:289–300.PubMedGoogle Scholar
  137. Peart, A. F. W., and Nagler, F. P., 1954, Measles in the Canadian Arctic 1952, Can. J. Pub. Health 45:146–157.Google Scholar
  138. Pecenková, I., Maixnerová, M., Fedová, D., and Tumová, B., 1972, Study of the distribution of M. parainfluenzae in the child population by serological survey methods, J. Hyg. Epidemiol. Microbiol. Immunol. 16:194–201.PubMedGoogle Scholar
  139. Pepping, F., Hackenitz, E. A., West, C. E., Duggan, M. B., and Franken, S., 1988, Relationship between measles, malnutrition and blindness, Am. J. Clin. Nutz. 47:341–343.Google Scholar
  140. Philip, R. N., Reinhard, K. R., and Lackman, D. B., 1959, Observations on a mumps epidemic in a “virgin population,” Am. J. Hyg. 69:91–111.PubMedGoogle Scholar
  141. Plowright, W., dy1968, “Rinderpest,” Springer-Verlag, Vienna.Google Scholar
  142. Potash, L., Lees, R., Greenberger, J. L., Hoyrup, A., Denny, L. D., and Channock, R. M., 1970, A mutant parainfluenza type 1 virus with decreased capacity for growth at 38°C and 39°C, J. Infect. Dis. 121:640–647.PubMedCrossRefGoogle Scholar
  143. Reed, D., Brown, G., Merrick, R., Sever, J., and Felz, E., 1967, A mumps epidemic on St. George Island, Alaska, J. Am. Med. Assoc. 199:967–971.CrossRefGoogle Scholar
  144. Ray, R., Brown, V. E., and Compans, R. W., 1985, Glycoproteins of parainfluenza type 3: Characterization and evaluation of a subunit vaccine, J. Infect. Dis. 152:1219–1230.PubMedCrossRefGoogle Scholar
  145. Richter, C. B., 1986, Mouse adenovirus, K virus, and pneumonia virus of mice, in “Viral and Mycoplasmal Infections of Laboratory Rodents” (P. N. Bhatt, R. O. Jacoby, H. C. Morse, and A. E. New, eds.), Academic Press, Orlando, Florida.Google Scholar
  146. Rossi, C. R., and Keisel, G. K., 1972, Epizootiologic study of parainfluenza-3 viral infection in calves in two Alabama herds, Am. J. Vet. Res. 33:2341–2349.PubMedGoogle Scholar
  147. Rydbeck, R., Löve, A., Örvell, C., and Norrby, E., 1987, Antigenic analysis of human and bovine parainfluenza virus type 3 strain with monoclonal antibodies, J. Gen. Virol. 68:2153–2160.PubMedCrossRefGoogle Scholar
  148. St. Gerne, J. W., Jr., Wright, F. S., Halbertt, F., and Anderson, J. A., 1959, Failure to detect subtle neurotropism of live, attenuated measles virus vaccine, J. Pediati. 70:36–45.CrossRefGoogle Scholar
  149. Schleuderberg, A. E., Chavanich, S., Litman, M. B., and Carter, C., 1974, Comparative molecular weight estimates of measles and subacute sclerosing panencephatitis virus structural polypeptides by simultaneous electrophoresis in acrylamide gel slabs, Biochem. Biophys. Res. Commun. 58:547–551.Google Scholar
  150. Schopfer, K., Germann, D., Eggenburger, K., Bachler, A., and Wunderli, W., 1986, Virale respiratorishe Infectionen bei Kindern: Neue diagnostische Methode zur Fruherfassung, Schweitzer Med. Woch. 116:502–507.Google Scholar
  151. Schutz, F., 1925, “Die Epidemiologie der Masern,” Gustav Fischer, Jena.Google Scholar
  152. Scrimshaw, N. S., Solomon, J. B., Bruch, H. A., and Gordon, J. E., 1966, Studies of diarrheal disease in Central America. VIII. Measles, diarrhea and nutritional deficiency in Guatemala, Am. J. Trop. Med. Hyg. 15:625–631.PubMedGoogle Scholar
  153. Sencer, D., Dull, H. B., and Langmuir, A. D., 1967, Epidemiologic basis for eradication of measles in 1967, Public Health Rep. 82:253–256.PubMedCrossRefGoogle Scholar
  154. Server, A. C., Merz, D. C., Waxham, M. N., and Wolinsky, J. S., 1982, Differentiation of mumps virus strains with monoclonal antibody, Infect. Immun. 35:179–186.PubMedGoogle Scholar
  155. Shanthikumar, S. R., Malachi, S. A., and Majiyagabe, K. A., 1985, Rinderpest outbreak in free living wildlife in Nigeria, Vet. Rec. 117:469–470.PubMedCrossRefGoogle Scholar
  156. Sheshberadaran, S. R., Norrby, E., McCullogh, K. C., Carpenter, W. C., and Örvell, C., 1986, The antigenic relationship between measles, canine distemper and rinderpest viruses studied with monoclonal antibodies, J. Gen. Virol. 67:1381–1392.PubMedCrossRefGoogle Scholar
  157. Shute, N., 1957, “On the Beach,” Morrow, New York.Google Scholar
  158. Smith, C. B., Purcell, R. H., Belanti, J. A., and Channock, R. M., 1966, Protective effect of antibody to parainfluenza virus type 1 virus, N. Engl. J. Med. 275:1145–1152.PubMedCrossRefGoogle Scholar
  159. Sutton, R. N. P., 1979, Slow viruses and chronic disease of the nervous system, Postgrad. Med. 55:143–149.CrossRefGoogle Scholar
  160. Taylor, W. R., Mambu, R. K., ma-Disu, M., and Weinman, J. M., 1988, Measles control in urban Africa complicated by high incidence of measles in the first year of life, Am. J. Epidemiol. 127:788–794.PubMedGoogle Scholar
  161. Thomson, J. R., Nettleton, P. F., Greig, A., and Barr, J., 1986, A bovine respiratory virus vaccination trial, Vet. Rec. 119:450–453.PubMedCrossRefGoogle Scholar
  162. Tobler, L. H., and Imagawa, D. T., 1984, Mechanism of persistence with canine distemper virus: Difference between a laboratory strain and an isolate from a dog with chronic neurological disease, Intervirology 21:77–86.PubMedCrossRefGoogle Scholar
  163. Tremonti, L. P., Lin, J. S. L., and Jackson, G. C., 1968, Neutralizing activity in nasal secretions and serum in volunteers to parainfluenza type 2, J. Immunol. 101:572–577.PubMedGoogle Scholar
  164. Tyeryar, F. J., Richards, L. S., and Belshe, R. B., 1978, Report of a workshop on respiratory synscytial virus and parainfluenza viruses, J. Infect. Dis. 137:835–846.PubMedCrossRefGoogle Scholar
  165. Vella, P. P., Weibel, R. E., Woodhour, A. F., Mascoli, C. C., Leagus, M. B., Ittensohn, O. L., Stokes, J. J., Jr., and Hilleman, M. R., 1969, Respiratory virus vaccine. VIII. Field evaluation of trivalent parainfluenza virus vaccine among preschool children living in families 1967–68, Am. Rev. Respir. Dis. 99:526–541.PubMedGoogle Scholar
  166. Vicens, C. N., Nobrega, F. T., Joseph, J. M., and Meyer, M. M., 1966, Evaluation of tests for measurement of previous mumps infection and analysis of mumps exposure by blood group, Am. J. Epidemiol. 84:371–381.PubMedGoogle Scholar
  167. Wagonvoort, J. H. T., Harmsen, M., Khader, B. J., Kraaijveld, C. A., and Winkler, K. C., 1988, Epidemiology of mumps in the Netherlands, J. Hyg. 85:313–326.CrossRefGoogle Scholar
  168. Walsh, J., 1987, War on cattle disease divides the troops, Science 237:1289–1291.PubMedCrossRefGoogle Scholar
  169. Ward, K. A., Lambden, P. R., Ogilvie, M. M., and Watt, P. J., 1983, Antibodies to respiratory syncytial virus polypeptides and their significance in human infection, J. Gen. Virol. 64:1867–1876.PubMedCrossRefGoogle Scholar
  170. Watt, P. J., Zardis, M., and Lambden, P. R., 1986, Age related IgG subclass response to respiratory syncytial virus fusion protein in infected infants, Clin. Exptl. Immunol. 64:503–509.Google Scholar
  171. WHO/UNICEF, 1987, Extended program on immunization and nutrition. Joint WHO/UNICEF statement on vitamin A for measles, EPI Newsl. Pan Am. Health Org. 9:(5):6–8.Google Scholar
  172. Wigley, F. M., Fructman, M. H., and Waldman, R. H., 1970, Aerosol immunization of humans with inactivated parainfluenza type 2 vaccine, N. Engl. J. Med. 283:1250–1253.PubMedCrossRefGoogle Scholar
  173. Wright, P. F., Shinovaki, T., Fleet, W, Sell, S. H., Thompson, J., and Karzon, D. T, 1976, Evaluation of live, attenuated respiratory syncytial virus vaccine in infants, J. Pediatr. 88:931–936.PubMedCrossRefGoogle Scholar
  174. Yorke, J. A., and London, W. P., 1973, Recurrent outbreaks of measles, chickenpox and mumps. II. Systematic differences in contact rates and stochastic effects, Am. J. Epidemiol. 98:469–478.PubMedGoogle Scholar
  175. Yorke, J. A., Nathanson, N., Pianigiani, G., and Martin, J., 1979, Seasonality and the requirements for perpetuation and eradication of viruses in populations, Am. J. Epidemiol. 109:103–123.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1991

Authors and Affiliations

  • Francis L. Black
    • 1
  1. 1.Department of Epidemiology and Public HealthYale University School of MedicineNew HavenUSA

Personalised recommendations